» Articles » PMID: 35211780

Phenotypic Subtypes of Progressive Dysexecutive Syndrome Due to Alzheimer's Disease: a Series of Clinical Cases

Abstract

Diagnostic criteria for a progressive dysexecutive syndrome due to Alzheimer's disease (dAD) were proposed. Clinical observations suggest substantial variability in the clinico-radiological profiles within this syndrome. We report a case series of 6 patients with dAD highlighting this heterogeneity. Average age at diagnosis was 57.3 years, and patients were followed annually with clinical, cognitive, and multimodal imaging assessments for an average of 3.7 years. Cases were divided based into three subtypes based on their pattern of FDG-PET hypometabolism: predominantly left parieto-frontal (ldAD), predominantly right parieto-frontal (rdAD), or predominantly biparietal (bpdAD) (n = 2 for each). Prominent executive dysfunction was evidenced in all patients. ldAD cases showed greater impairment on measures of verbal working memory and verbal fluency compared to other subtypes. rdAD cases showed more severe alterations in measures of visual abilities compared to language-related domains and committed more perseverative errors on a measure of cognitive flexibility. bpdAD cases presented with predominant cognitive flexibility and inhibition impairment with relative sparing of working memory and a slower rate of clinical progression. rdAD and bpdAD patients developed neuropsychiatric symptoms, whereas none of the ldAD patients did. For each subtype, patterns of tau deposition relatively corresponded to the spatial pattern of FDG hypometabolism. dAD cases could be differentiated from two clinical cases of atypical AD variants (language and visual) in terms of clinical, cognitive and neuroimaging profiles, suggesting that dAD subtypes represent clinical entities separable from other variants of the disease. The recognition of distinct dAD phenotypes has clinical relevance for diagnosis, prognosis, and symptom management.

Citing Articles

Assessing network degeneration and phenotypic heterogeneity in genetic frontotemporal lobar degeneration by decoding FDG-PET.

Corriveau-Lecavalier N, Barnard L, Przybelski S, Gogineni V, Botha H, Graff-Radford J Neuroimage Clin. 2023; 41:103559.

PMID: 38147792 PMC: 10944211. DOI: 10.1016/j.nicl.2023.103559.


Uncovering the distinct macro-scale anatomy of dysexecutive and behavioural degenerative diseases.

Corriveau-Lecavalier N, Barnard L, Botha H, Graff-Radford J, Ramanan V, Lee J Brain. 2023; 147(4):1483-1496.

PMID: 37831661 PMC: 10994526. DOI: 10.1093/brain/awad356.


How Many Alzheimer-Perusini's Atypical Forms Do We Still Have to Discover?.

Donato L, Morda D, Scimone C, Alibrandi S, DAngelo R, Sidoti A Biomedicines. 2023; 11(7).

PMID: 37509674 PMC: 10377159. DOI: 10.3390/biomedicines11072035.


Default mode network failure and neurodegeneration across aging and amnestic and dysexecutive Alzheimer's disease.

Corriveau-Lecavalier N, Gunter J, Kamykowski M, Dicks E, Botha H, Kremers W Brain Commun. 2023; 5(2):fcad058.

PMID: 37013176 PMC: 10066575. DOI: 10.1093/braincomms/fcad058.


Deciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer's disease.

Corriveau-Lecavalier N, Barnard L, Lee J, Dicks E, Botha H, Graff-Radford J Cereb Cortex. 2023; 33(11):7026-7043.

PMID: 36721911 PMC: 10233237. DOI: 10.1093/cercor/bhad017.


References
1.
Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B . Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol. 2001; 58(3):373-9. DOI: 10.1001/archneur.58.3.373. View

2.
Baddeley A . The fractionation of working memory. Proc Natl Acad Sci U S A. 1996; 93(24):13468-72. PMC: 33632. DOI: 10.1073/pnas.93.24.13468. View

3.
Baddeley A . Working memory: theories, models, and controversies. Annu Rev Psychol. 2011; 63:1-29. DOI: 10.1146/annurev-psych-120710-100422. View

4.
Bang J, Spina S, Miller B . Frontotemporal dementia. Lancet. 2015; 386(10004):1672-82. PMC: 5970949. DOI: 10.1016/S0140-6736(15)00461-4. View

5.
Bassiony M, Steinberg M, Warren A, Rosenblatt A, Baker A, Lyketsos C . Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates. Int J Geriatr Psychiatry. 2000; 15(2):99-107. DOI: 10.1002/(sici)1099-1166(200002)15:2<99::aid-gps82>3.0.co;2-5. View